Hauttumorcentrum der Charite (HTCC)-Charite Universitatsmedizin Berlin

Berlin C-10117

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Basal Cell

Studies at this site

• PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy — Completed